What is Feral cannabis?
Feral cannabis is referred to as ditch weed in the United States. It is wild-growing cannabis generally declines from industrial hemp plants with a low amount of psychoactive tetrahydrocannabinol. Some entities are putting efforts to eliminate the plant and others consider as a low priority. Feral cannabis is a hardy weed, it took 7 to 10 years before sprouting again. It is produced for fiber, so it typically has low amounts of THC, and majorly found in Midwest and states like Missouri, Iowa, and Minnesota. It is considered to be low-quality buds because it is not fertilized or tended to.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | Cara Therapeutics, Inc. (United States), Cannabis Sativa, Inc. (United States), CannaGrow Holdings, Inc. (United States), Aphios Corporation (United Kingdom), United Cannabis Corporation (United States), Growblox Sciences, Inc. (United States), GreenGro Technologies, Inc. (United States) and GW Pharmaceutical, PLC. (United States) |
The study covers a detailed analysis segmented by key business segments i.e. , by application (Chronic Pain, Arthritis, Migraine, Cancer and Other) and major geographies. Research Analyst at AMA predicts that Japan Vendors will contribute to the maximum growth of Global Feral cannabis market throughout the predicted period.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Feral cannabis market report suggests strategies that Vendors can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Vendors, some of them are Cara Therapeutics, Inc. (United States), Cannabis Sativa, Inc. (United States), CannaGrow Holdings, Inc. (United States), Aphios Corporation (United Kingdom), United Cannabis Corporation (United States), Growblox Sciences, Inc. (United States), GreenGro Technologies, Inc. (United States) and GW Pharmaceutical, PLC. (United States).
Market Overview:
In November 2021 Vertically integrated cannabis company and Gage Growth Corp. has secured a senior secured term loan to support retail acquisitions in Michigan and provide working capital.The company, which trades on the Canadian Securities Exchange and is in the process of being acquired by TerrAscend Corp.
The global feral cannabis market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensification their market share and escalation their profitability.
Influencing Trend:
Transition to Adult-Use Cannabis and Health Safety in Cannabis Products
Market Growth Drivers:
Rising geriatric population in need of treatment for chronic diseases and Increasing Research and Development Activities
Challenges:
The Producers Biggest Fear Is the Possibility That Derivatives Are Going To Be Pharmaceutical Only and The Main Issue Is That There Is Much Regulation of CBD Products for All European Countries
Restraints:
Stringent FDA and other regulations
Opportunities:
High demands
Key highlights of the Global Feral cannabis market Study:
CAGR of the market during the forecast period 2023-2030
In-depth information on growth factors that will accelerate the Feral cannabis market in next few years.
Detailed Insights on futuristic trends and changing consumer behavior
Forecast of the Global Feral cannabis market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Vendors
Comprehensive information about factors that will challenge the growth of Feral cannabis Vendors
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Feral cannabis market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Feral cannabis market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Ferel Cannabis Suppliers and Distributors, Government Regulatory and Research Organizations and End-Use Industries.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.